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Abstract
Background: Most virus detection methods are geared towards the detection of specific single
viruses or just a few known targets, and lack the capability to uncover the novel viruses that cause
emerging viral infections. To address this issue, we developed a computational method that
identifies the conserved viral sequences at the genus level for all viral genomes available in GenBank,
and established a virus probe library. The virus probes are used not only to identify known viruses
but also for discerning the genera of emerging or uncharacterized ones.
Results: Using the microarray approach, the identity of the virus in a test sample is determined by
the signals of both genus and species-specific probes. The genera of emerging and uncharacterized
viruses are determined based on hybridization of the viral sequences to the conserved probes for
the existing viral genera. A detection and classification procedure to determine the identity of a
virus directly from detection signals results in the rapid identification of the virus.
Conclusion: We have demonstrated the validity and feasibility of the above strategy with a small
number of viral samples. The probe design algorithm can be applied to any publicly available viral
sequence database. The strategy of using separate genus and species probe sets enables the use of
a straightforward virus identity calculation directly based on the hybridization signals. Our virus
identification strategy has great potential in the diagnosis of viral infections. The virus genus and
specific probe database and the associated summary tables are available at http://
genestamp.sinica.edu.tw/virus/index.htm.
Background
New human viral pathogens, such as the etiologic agent
causing severe acute respiratory syndrome (SARS) and
avian influenza, continue to emerge and have become
major health problems worldwide. Traditional viral detec-
tion techniques such as in vitro viral cultures, immuno-
logic assays, and the PCR method [1] can identify only
one or just a few specific viral targets in a single test. When
presented with patients having symptoms of unknown
etiology, multiple diagnostic assays are often performed
in parallel, which is a time-consuming and labor-inten-
sive process.
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Oligonucleotide microarrays have been used for monitor-
ing and analyzing viral pathogens [2-5]. There are cur-
rently two types of DNA microarrays used for virus
identification: (i) those based on using short oligonucle-
otide probes that are sensitive to single-base mismatches,
which are used to detect or identify subtypes of known
viruses; and (ii) those based on using long oligonucle-
otide probes to uncover the identity of the virus present in
a sample. For the former application, the entire set of
probes on the microarray is designed to detect the muta-
tions in the viral genome to allow one specific viral species
and its subtypes to be discerned. An example of this appli-
cation is the virus microarrays for discriminating different
subtypes of influenza viruses [4,5]. For the latter applica-
tion, long oligonucleotide probes (60- or 70-mers) that
tolerate sequence mismatches are used for broad detec-
tion specificity to a large number of viruses. This study
focuses on the latter application: uncovering the identity
of viruses present in a sample rather than detecting the
mutations of a specific known virus.
Previously reported studies [2,3] have employed the tiling
approach (70-nt segments with 25-nt offsets) to design
microarray probes for uncovering the identities of viruses
in a sample, using the BLASTN sequence alignment pro-
gram to select the most similar sequences in the respective
viral family of each sequenced viral genome. The
unknown or unsequenced members of existing viral fam-
ilies can be detected by hybridization to the microarray
elements with sequence similarity. Conserved sequences
were selected based only on the unidirectional relation-
ship between one genome and the others in the same viral
family. A substantial percentage of sequence redundancy
exists among these family probes, and a family probe set
usually contains a large number of redundant conserved
probes. For virus identification, microarray data have
been categorized into individual viral families and con-
verted to a linear visualization scale (a bar-coded linear
pattern) [2] or an alignment of the probe sequences giving
hybridization signal intensities has been employed to
determine the true identity of specific viruses [3].
Based on the experiences of identifying novel viruses, such
as the SARS coronavirus (SARS-CoV) or the Nipah virus, a
virus can exhibit considerable sequence identity with
other viruses in the same genus [6,7]. Although long
probes possess a high hybridization efficiency, they often
exhibit poor discrimination of specific viruses. Therefore,
significant cross-hybridization of a viral genome to the
highly similar noncognate long probes is expected. Thus,
identifying viral species using the previously reported viral
microarray probe design strategy requires additional
intensive computation to analyze the complex hybridiza-
tion patterns. A software program for implementing such
a virus identification strategy has been developed [8]. The
program determines the identity of specific virus(es) in a
test sample by comparing observed patterns of microarray
hybridization intensities with a set of theoretical hybridi-
zation energy profiles as computed from the alignments
of microarray oligonucleotides against all completely
sequenced reference viral genomes available in the Gen-
Bank database.
In order to design a virus microarray capable of identify-
ing a larger number of viruses with high accuracy but with
fewer probes than previously reported, we have developed
a new method for designing probes for the precise and
direct identification of viruses at the genus, species, and
strain levels. Our method narrows down the computation
of conserved sequences to the genus level and eliminates
sequence redundancy within a viral genus probe set by
considering the mutual sequence similarity among all the
viral genomes in the same genus. Compared with the til-
ing approach, our approach greatly reduces the redun-
dancy and number of conserved probes for a given viral
genus. The method involves two separate sets of probes:
(i) the conserved sequence probes for genus identifica-
tion; and (ii) specific probes for viral species or stain iden-
tification. The probe set for each genus contains a panel of
70-mer oligonucleotides that not only covers all the
sequenced known viruses of the genus but also maximizes
the likelihood of detecting emerging or unsequenced
viruses. Long 70-mer probes help to alleviate sequence-
dependent hybridization variation, improve hybridiza-
tion efficiency, and enhance the capability of identifying
unknown viruses. To compensate for the poor discrimina-
tion capability of long probes, additional species- or sub-
type-specific probes were designed for each fully
sequenced virus to enhance the specificity of virus identi-
fication. The identity of a virus is determined based on a
simple arithmetic algorithm that calculates the average
signal intensity of the multiple probes for a virus, in con-
trast to the intensive computation needed for pattern
comparisons. The use of separate genus and species probe
sets facilitates a cross-examination strategy to increase the
identification accuracy. The identity of a virus is estab-
lished by the concordant results for both the genus- and
cognate-species-specific probes.
Results
Viral sequences for computation
More than 19,600 full-length viral genomes covering 53
viral families and 214 genera were obtained from ~
340,000 viral sequences archived in the GenBank viral
database (Release 152). The genome segments of the
viruses with segmented or multipartite genomes were
treated as individual viral sequences. Additional partially
sequenced viral genomes were included for computing
the conserved genus probes for genera with ≤ 5 fully
sequenced members and viruses with segmented or mul-BMC Bioinformatics 2006, 7:232 http://www.biomedcentral.com/1471-2105/7/232
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tipartite genomes, which made up a total number of
27,610 viral genome sequences for the computation. Viral
genome sequences with more than 99.5% similarity were
treated as redundant, and only the longest sequences were
retained; the resulting 5,749 nonredundant viral genome
sequences were used in the analysis.
Algorithm for designing the conserved probe
The probe design strategy employs two separate probe
sets: species-specific probes and conserved genus probes.
Genera with insufficient viral sequences for identifying
conserved probe sequences are marked in the virus probe
database and extra species-specific probes are designed for
each viral species of each such genus. The species-specific
probes were designed using the algorithm described by
Chang and Peck [9], and the conserved genus probes for
each viral genus were designed according to the following
guidelines:
1. A viral genus G = {vi| i = 1,..., n} is a collection of n
viruses, in which each virus vi (i = 1,..., n) is associated
with a subset of G, where subset G(i) ≡ G-{vi}.
2. Given a virus vi ∈G, the BLASTN result for the compari-
son of this virus with another virus in the same genus, vj
∈G(i), can be expressed as an indicator function Iji:
where x is any sequence segment within the genome of vi,
and the similarity sequence segment is any segment of
virus vi having either (i) more than 75% local sequence
similarity in a 50-bp window with any virus vj ∈G(i), as
determined using the identity percentage calculation in
the BLASTN program (equivalent to BLASTN sequence
identity matches of 38-bp); or (ii) >15 consecutive bases
pairing with vj [10].
3. The sequence segments of virus vi similar to other
viruses in G(i) are then defined as the summation of all
these indicator functions,Si(x) = ∑j≠i Iji(x), which is a step
contour function from 0 to n-1.
4. The conserved sequences of vi are defined as the regions
with the maximum number of similarity hits in Si(x): Ci =
{x| Si(x) =   (Si(x))}.
5. The conserved sequence set of G is the union of all Ci's:
C'(G) =  . To eliminate sequence redundancy, the
longest sequence segment CL  (the query sequence) in
C'(G) is selected first and aligned against the other
sequences in it using the BLASTN program. Any sequences
in  C'(G)-{CL} having ≥ 80% similarity with CL  are
grouped together with CL to form C'1(G), the first sub-
group of C'(G). CL is then renamed as C(1) to represent the
first subgroup. The first subgroup,C'1(G), is then excluded
from C'(G). This procedure is repeated for the remaining
sequence segments in C'(G) until k such longest sequence
segments {C(1),..., C(k)  and  k  subgroups {C'1(G),...,
C'k(G)} are identified, with every sequence in C'(G)
assigned to one subgroup. The union of all the longest
sequences,  , represents the nonredundant con-
served sequence set of G. A simplified illustration deline-
ating the above procedures is provided in Additional File
1.
6. To prevent significant cross-hybridization to noncog-
nate viral genus sequences, a 70-mer conserved probe set
P = {pj| j = 1,..., m is selected from each nonredundant
sequence in   based on the following criteria: (i)
GC content between 40% and 60%, (ii) <5 continuous
mononucleotide repeats, (iii) <25-bp BLASTN sequence
identity matches, and (iv) ≤ 15 consecutive bases pairing
with other viral sequences in the noncognate viral genus.
The probes exhibiting sequence overlap are further
screened using the Mfold program [11] to pick the one
that has the maximal Gibbs free energy of the secondary
structure, such that there is no sequence overlap among P.
7. To search for a subset of P with the minimum number
of probes that can collectively yield similarity hits with all
the virus members of G, each pj ∈P is aligned against vi ∈G
using the BLASTN program. The BLASTN result between pj
and vi can be expressed as an array,Aj × i:
Thus, the 70-mer conserved probe set can be redefined as
P = {pj| j = 1,..., m}, pj ⊆G', and G' = {v'i| i = 1,..., m, where
v'  i  represents similarity hit(s) with vi  by  pj(s)  ∈P. Let
Card(pj) be the cardinality of probe pj (i.e., the number of
similarity hits with probe pj) in array Aj × i. We first search
for a minimum coverage set   ⊆ P such that Card()  =
min Card(PS ) for all subsets of P (PS ⊆ P) satisfying the fol-
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lowing sequential criteria: (i)  [12,13],
(ii) max   if more than one set of 
having Card( ) = min Card(PS), and (iii) randomly pick
one of those   with the same max   if
more than one set of   satisfy condition (ii). We then
keep searching for other subsets of P-  with the same cri-
teria until the probe set finally has a twofold coverage of
G.
Illustration of the conserved sequence design method
To demonstrate the conserved sequence design method, a
simplified example of the procedure is shown in Figure
1A. Assuming that there are six (n) viruses in a viral genus
(G), the similarity sequence segments for a given virus vi
compared to the other five (n-1) viral genomes (G(i)) are
designated Iji (j = 1,..., 5) (Fig. 1A). These similarity seg-
ments are then ranked by the number of similarity hits
with other viral genomes (Si) and plotted along the vi
genome. The highest-ranking (max(Si)) similarity
sequences should be the most-conserved sequences (Ci)
for virus vi and the other five viral genomes (red segments
in Fig. 1B).
The above procedures are repeated until a panel of con-
served segments derived from all of the viral genomes in
G is obtained. Assuming that nine 70-mer candidate con-
served probes (P = {pj| j = 1,..., 9}) are selected by steps 5
and 6 in the probe design algorithm, Table 1 (Figure 2)
demonstrates how to search for the minimal number of
70-mer genus probes that give similarity hits with all six
viral members (vi| i = 1,..., 6) of G. Each "×" in Table 1
(Figure 2) indicates that pj has a similarity hit with vi.
Based on the similarity-hit array (A9 × 6), at least two
probes (Card( )) are required for the full detection of all
the viruses in G. Among the eight two-element probe sets
(  ≡ {(p1, p3), (p1, p4), (p1, p5), (p1, p6), (p1, p7), (p1, p9),
(p2, p4), (p3, p4)}) that can collectively yield similarity hits
with all the virus members of G ( ), probe
set (p1,  p4) is the best selection since the two probes
together maximize the similarity hits (max
 = 10) with G and therefore increase
the likelihood of detecting a virus. Subsequently, probe
set (p2, p5, p8) is randomly selected for second-round cov-
erage of G among the three probe sets (p2, p5, p8), (p2, p7,
p9), and (p2, p8, p9) because all of them produce the same
eight similarity hits with all the virus members of G.
We subsequently used the coronavirus genus to test the
procedure for finding similar viral sequence segments.
The SARS-CoV genome (vSARS-CoV) was aligned with the
other 10 genomes G(SARS-CoV) of the coronavirus genus
using the BLASTN program (Fig. 1C). In the figure, each
viral genome of the coronavirus genus is represented by a
color-coded block, where the height of each pile of blocks
along the SARS-CoV genome sequence represents the
number of similarity hits (SSARS-CoV) with the other 10
genomes of the same genus for that particular sequence
location (i.e., segment). The two viral segments showing
the highest number of similarity hits with the other
genomes (CSARS-CoV) were extracted for microarray probe
design.
In silico validation of the conserved sequence detection 
method
To validate the method in silico, the SARS-CoV genome
was removed from the coronavirus genus and treated as a
test genome. The remaining 10 coronavirus viral genomes
were used as the calibration set for computing the con-
served sequences by the aforementioned procedures. To
obtain high similarity genus probes, we used a high strin-
gency criterion for hybrid formation in the conserved
sequence detection method: 38-bp BLASTN sequence
identity matches or >15 consecutive base pairing nucle-
otides [10]. Figure 3A shows the computed conserved
sequence segment pool with redundancy (i.e., C'(Corona-
virus(SARS-CoV)) in step 5 of the above probe design algo-
rithm). These segments can be further sorted into five
nonredundant groups by the BLASTN alignment program.
The five longest sequences (underlined sequences in Fig.
3A) in each of the groups represent the nonredundant
conserved sequence set of the coronavirus genus without
SARS-CoV. A BLASTN sequence alignment between the
SARS-CoV genome and the five nonredundant conserved
sequences shows that the longest conserved sequence in
group 1 had 80% (79/98) sequence similarity with the
SARS-CoV genome at nucleotide positions from 15732 to
15829 (Fig. 3B) but no significant similarity with any
genome in the other viral genera (data not shown).
To provide a more comprehensive in silico validation, we
also performed leave-one-out cross-validation to the
other viral members of the coronavirus genus and 13
other viral genera. In total, 14 viral genera and 333 nonre-
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dundant viral genome sequences were included in the
large-scale cross-validation to verify the probe design
algorithm (Fig. 3C). Based on a recent report that BLASTN
sequence identity matches as short as 25-bp are sufficient
to form a DNA hybrid [3], a lower hybrid formation crite-
rion (25-bp vs. 38-bp BLASTN identity) was used to deter-
mine whether a test viral genome can be detected by a set
of conserved sequences computed from the calibration
genome set for a given genus. In Figure 3C, the column
entitled "sequenced genomes" lists the number of viruses
included for the computation in each genus, and the col-
umn entitled "detection by cross-validation" contains the
Algorithm for designing conserved probes Figure 1
Algorithm for designing conserved probes. Schematic illustration of the conserved sequence design method. (A) The 
similarity sequence segments (I1i to I5i) of a given virus vi are aligned with the sequence segments of the other five viruses within 
the same viral genus by the BLASTN program to find the regions with high similarity hits. (B) Graph of the numbers of similar-
ity hits, Si, obtained by the procedure illustrated in panel A. The largest number of hits as illustrated is max(Si), which equals 4. 
The two regions with the highest similarity hits are marked by vertical dotted lines. (C) A case study of locating the conserved 
sequence segments in coronavirus genus. The genus contains the following 11 fully sequenced viral genomes: NC_002645, 
human coronavirus 229E; NC_001451, avian infectious bronchitis virus; NC_003436, porcine epidemic diarrhea virus; 
AF201929, murine hepatitis virus strain 2; AF208067, murine hepatitis virus strain ML-10; AF208066, murine hepatitis virus 
strain Penn 97-1; NC_001846, murine hepatitis virus strain A59; NC_003045, bovine coronavirus; AF220295, bovine coronavi-
rus strain Quebec; NC_002306, transmissible gastroenteritis virus; and SARS-CoV, SARS coronavirus.BMC Bioinformatics 2006, 7:232 http://www.biomedcentral.com/1471-2105/7/232
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number of viruses detected using the in silico method for
each genus. The rightmost column is the positive detec-
tion rate for the in silico method for each genus. The com-
putation results showed that most of the computed genus
probes – especially for those genera having a larger
number of sequenced viral genomes – displayed a good
capability of detecting novel viruses, except for the genus
of lentivirus, which yielded a worse prediction outcome.
This result indicates that both the number of sequenced
genomes and the extent of sequence conservation of viral
members in a genus are useful factors for assessing the
predictive power of the computed conserved sequences.
Nevertheless, the in silico cross-validation results pro-
duced an average successful detection rate of 92%, which
demonstrates the feasibility of the probe design method.
Experimental verification
To experimentally verify the probe design method, we
constructed a test virus chip with 72 70-mer oligonucle-
otides, which included genus probes covering 3 viral gen-
era (7 conserved probes for coronavirus, 12 probes for
flavivirus, and 7 probes for enterovirus) and specific
probes covering 26 species of viruses in the coronavirus (7
species) and flavivirus (19 species) genera (see Additional
File 2). A blank control (A549 lung adenocarcinoma cells)
and seven viral samples [Japanese encephalitis virus (JEV),
dengue virus types 2 (DEN-2), 3 (DEN-3), and 4 (DEN-4),
SARS-CoV, enterovirus 71 (EV71), and a mixture of EV71
and SARS-CoV (EV71+SARS-CoV)], all of which are path-
ogens found in nasopharyngeal swabs, were used for the
experiments.
The identity test results for the seven test samples are
shown in Figure 4. The virus genus and species identifica-
tion methods are described in the Methods section. In Fig-
ure 4A, the Z-axis represents the genus signal strengths of
the three genus probe sets (Y-axis) hybridized to the seven
test viral samples (X-axis). The possible genus identity (or
identities) of a test viral sample can be determined from
the magnitude of the genus signal. Figure 4B demon-
strates the determination of the identity of a specific virus.
The Z-axis is the specific signal strengths of 26 virus probe
sets (Y-axis) hybridized to the 7 test viral samples (X-axis).
The specific identity of the test virus can be read directly
from the extent of the specific signal strength in the chart.
Verifying the results for the genus-specific (Fig.4A) and
cognate-species-specific (Fig. 4B) probes with virus taxon-
omy (i.e., the correct hierarchical genus and species asso-
ciation) results in the identities of all the test viruses being
determined accurately and unambiguously. Figure 4 also
demonstrates the use of this method for detecting emerg-
ing and unsequenced viruses. We intentionally left out
EV71 sequence information in the conserved probe
design process and made no EV71 species-specific probes
on the test chip. However, the hybridization of EV71 to
the chip resulted in a high signal intensity for the entero-
virus genus probes, which clearly indicated that the virus
belonged to this genus (Fig. 4A). Moreover, as shown by
the hybridization result of the mixed viral sample
EV71+SARS-CoV (Fig. 4A), the probe design method also
allows two viruses of different genera to be accurately
identified simultaneously. Although JEV cross-hybridized
to three noncognate virus probes [Fig. 4B for Murray Val-
ley encephalitis virus (MEV), West Nile virus (WNV), and
Louping ill virus (LIV)] that are of the same genus as flavi-
virus, the signal strength resulting from the specific
hybridization of JEV to its probe was 5-, 30-, and 33-fold
higher than that of the probes for the three other viruses,
respectively. Therefore, the virus was correctly identified
as JEV. All the experiments were performed at least twice.
In some cases, the signal intensity of the probes varied in
different experiments for the same viral sample. However,
our strategy for determining identities exhibits high sig-
nal-to-background ratios (as shown in Figure 4) and is
Table 1 - Example searching the minimum number of probes that generate similarity hits with all the virus members within a  viral genus Figure 2
Table 1 - Example searching the minimum number of probes that generate similarity hits with all the virus members within a 
viral genus.
yg
similarity hit array (A9×6) of the viral genus G  Computation of minimum probe number for full genus coverage 
Virus (vi|i=1,…, 6) in G 1aji
v1 v2 v3 v4 v5 v6
2Card (pj) 
3Ps
*4 Card (Ps
*) ∑ j Card (pj| j∈P*)  Genus coverage/ 
probe set union 
p1 x x x x x    5  p1, p4 2 10  1-fold  p1, p4
p2 x x      x    3  p2, p5, p8 3  8  2-fold  p1, p2, p4, p5, p8
p3  x       x  2  p3, p6, p7, p9 4  9  3-fold  p1- p9
p4   x x x x x  5  Note 
p5  x    x  x  3 
p6    x      x  2 
p7     x     x  2 
p8    x x     2 
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1.  aji is the element within the similarity-hit array  A9×6. 
2.  Card (pj) is the number of similarity hits to probe pj. 
3.  Ps
*is a subset of P with the minimum number of probes that can collectively 
yield similarity hits to all the virus members of G.
4.  Card (Ps
*) is the number of probes in Ps
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In silico validation of the conserved sequence design method Figure 3
In silico validation of the conserved sequence design method. All of the fully sequenced viral genomes (except that of 
SARS-CoV) in the coronavirus genus were used to determine the conserved sequences. The design method was validated by 
testing if the computed conserved sequences could successfully detect the novel SARS-CoV. (A) The redundant conserved seg-
ments as computed by steps 1 to 4 of the probe design algorithm were reduced to five nonredundant sequence groups by the 
BLASTN sequence alignment in step 5 of the probe design algorithm. The longest sequence (underlined sequence) in each 
group was used to represent the group. (B) BLASTN results for the comparison of the group 1 conserved sequence with the 
SARS-CoV genome. The BLASTN alignment outputs are shown in the figure. The sequence alignment with the SARS-CoV 
genome shows that the group 1 conserved sequence is located between nucleotides 15732 and 15829 of the SARS-CoV 
genome. (C) Larger-scale cross-validation of 14 viral genera consisting of 333 nonredundant sets of viral genomes.
A
TATCAAAATAATGTGTTTATGTCTGAGGCTAAATGTTGGGTCGAAACAGACATCGAAAAGGGACCACATGAATTTTGTTCTCAACACACAATGCTAGT
TATCAAAATAATGTGTTTATGTCTGAGGCTAAATGTTGGGTCGAAACAGACATCGAAAAGGGACCACATGAATTTTGTTCTCAACACACAATGCTAGT
TATCAAAATAATGTGTTTATGTCTGAGGCCAAATGTTGGGTAGAAACAGACATCGAAAAGGGACCGCATGAATTTTGTTCTCAACATACAATGCTAGT 1 TATCAAAATAATGTGTTTATGTCTGAGGCCAAATGTTGGGTAGAAACAGACATCGAAAAGGGACCGCATGAATTTTGTTCTCAACATACAATGCTAGT
TATCAGAATAATGTTTTTATGGCTGATTCTAAATGTTGGGTTGAACCAGATTTAGAAAAAGGCCCACATGAGTTTTGTTCACAACACACAATGCT
TATCAAAATAACGTTTTTATGTCAGAATCCAAATGTTGGGTTGAAAATGACATAAATAATGGACCTCATGAATTCTGTTCACAACACACAATGCT
TATGAGGCATTATCATTTGAGGAACAGGATGAAGTTTATGCGTACACTAAGCGCAACGTCCTGCC
2 TATGAGGCATTATCATTTGAGGAACAGGATGAAGTTTATGCGTACACTAAGCGCAACGTCCTGCC
TATGAGTCTTTATCCTATGAGGAACAGGATGAACTTTATGCTT
CAGGATTCTTATGGTGGTGCTTCCGTTTGTATATATTGCCGCTCGCGTGTTGAACATCCAGATGTTGATGGATT
CAGGATTCTTATGGTGGTGCTTCCGTTTGTATATATTGCCGCTCGCGTGTTGAACATCCAGATGTTGATGGATT
3 CAGGATTCTTATGGTGGTGCTTCCGTTTGTATATATTGCCGCTCGCGTGTTGAACATCCAGATGTTGATGGATT
CAGGATTCTTATGGTGGTGCTTCCGTTTGTATATATTGCCGCTCGCGTGTTGAACATCCAGATGTTGATGGATT
CAGGACTCTTATGGTGGTGCTTCAGTTTGTATTTATTGCAGATGCCATGTTGAACATCCTGCTATTGATGGATT
TTATGTTAAGCCTGGTGGCACTAGTAGTGGTGATGCAACTACTGCTTTTGCTAATTCAGTTTTTAACATATGTCAAGCTGTTTCAGCCAATGT
4 TTATGTTAAGCCTGGTGGCACTAGTAGTGGTGATGCAACTACTGCTTTTGCTAATTCAGTTTTTAACATATGTCAAGCTGTTTCAGCCAATGT
AATGGTGGGTCATTGTATGTCAATAATCATGCATTTCACACTCCTGCTTATGATA 5
ʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳʳ
B
Score = 79.5 bits (41), Expect = 1e-12 
Identities = 79/98 (80%) 
Strand = Plus / Plus
15732 - 15829
SARS-CoV genome
Query: 1      TATCAAAATAATGTGTTTATGTCTGAGGCTAAATGTTGGGTCGAAACAGACATCGAAAAG 60
||||||||||||||||| ||||||||||| |||||||||   || || ||| | ||
Sbjct: 15732 TATCAAAATAATGTGTTCATGTCTGAGGCAAAATGTTGGACTGAGACTGACCTTACTAAA 15791 
Query: 61     GGACCACATGAATTTTGTTCTCAACACACAATGCTAGT 98
||||| || |||||||| || || || ||||||||||| 
Sbjct: 15792 GGACCTCACGAATTTTGCTCACAGCATACAATGCTAGT 15829 
C
Viral genus Sequenced
genomes
Detection by
cross-validation
Positive detection rate
(%)
Mastadenovirus 31 31 100.0
Hantavirus 27 24 88.9
Coronavirus 11 11 100.0
Flavivirus 21 19 90.5
InfluenzaB 24 23 95.8
Papillomavirus 119 109 91.6
Dependovirus 16 15 93.8
Enterovirus 11 10 90.9
Foot-and-mouth Virus 7 7 100.0
Orthopoxvirus 7 7 100.0
Aquareovirus 22 20 90.9
Gammaretrovirus 13 11 84.6
Lentivirus 9 5 55.6
Alphavirus 15 14 93.3
Total viral genomes 333 306ʳ ʳ
Average Success (%) ʳ ʳ ʳ ʳ ʳ 91.9BMC Bioinformatics 2006, 7:232 http://www.biomedcentral.com/1471-2105/7/232
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Viral genus classification and specific virus identification Figure 4
Viral genus classification and specific virus identification. Hybridization and identification results for seven test viral 
samples. The probes eligible for identity determination were prescreened using the hybridization intensity criteria described in 
the Methods section. (A) Viral genus determination for the seven viral samples, all of which belong to three viral genera. The 
genus signal strength is defined in the Methods section. (B) Determination of the identities of specific viruses. The numbers on 
the Y-axis are the ID numbers of the virus targets as listed in Additional File 2. Note that there are 46 species-specific probes 
for 26 viruses in the flavivirus and coronavirus genera, and that there are no enterovirus-specific probes.BMC Bioinformatics 2006, 7:232 http://www.biomedcentral.com/1471-2105/7/232
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both accurate and reproducible. Taken together, these
results demonstrate the high specificity of the virus chip
design.
Discussion
The two conserved sequence fragments are highly similar
to all of the coronavirus viral genomes archived in Gen-
Bank (Fig. 1C). This is not true in all cases: in general,
most of the conserved sequences have significant similar-
ity hits only with a fraction of the viral genomes in a
genus. As demonstrated in Table 1 (Figure 2), the design
method selects a panel of conserved genus probes, each
one similar to several (but not all) of the viral genomes of
a genus. The use of the whole panel of probes covers all
the viral genomes of a genus. To enhance the capability of
detecting emerging or unsequenced viruses, we created
multiple probes sufficient for twofold coverage of the
entire virus members in a genus.
The robustness of the computed genus probes is deter-
mined mainly by two parameters: (i) the number of exist-
ing fully sequenced viral genomes in a genus, and (ii) the
degree of genome structure diversity for the viral members
of the same genus. A larger number of available sequenced
viral genomes in a genus makes it easier to identify the
conserved sequences of the genus, and greatly enhances
the probability of detecting unknown or unsequenced
members of the genus. In addition, traditional virus tax-
onomy is not based on viral genome sequences. Thus, in
some cases, the viral genomes are highly divergent among
the members of a genus, such that each computed genus
probe is only similar to a small fraction of the genus mem-
bers, or may even be unique. The genus of lentivirus is one
example, for which a poor detection rate (55.6%) based
on  in-silico  cross-validation of the conserved genus
sequences is shown in Figure 3C.
The principle behind the conserved probe design is to
search for high similarity sequences that could hybridize
to all the virus members of a given genus but not to the
viruses of other genera. Therefore, accurate prediction of
cross-hybridization is a prerequisite for the feasibility of
the probe design method. In general, 70–80% global
sequence similarity or a high local sequence similarity
between two sequences could cause substantial cross-
hybridization [10,14-16]. Significant cross-hybridization
was reported for a nontarget 70-mer probe that had a
(short) 25-bp BLASTN identity match [3]. To obtain as
many reliable genus probes as possible, we used a 38-bp
BLASTN sequence identity match criterion [10] in the
genus probe design. This criterion was chosen to take into
account both the global and the local sequence similari-
ties in hybrid formation. Our experimental results show
that the criterion reduces false-positive and -negative pre-
dictions of hybrid formation. Additionally, the number of
genus probes sufficient for twofold coverage of all virus
members in a genus ensures high detection accuracy in
cases where the hybrid formation criterion may not apply.
The experimental results shown in Figure 4 indicate that
the hybrid formation criteria used in the genus probe
design are sufficient to yield detectable genus probe sig-
nals to the target viruses but not to viruses of non-target
genera.
The accurate detection of specific viruses by species-spe-
cific probes depends on avoiding nontarget cross-hybrid-
ization. Nevertheless, cross-hybridization to strains of
viruses with extremely similar genome sequences or by
confounding mechanisms may be inevitable. For exam-
ple, to investigate the JEV cross-hybridization issue in Fig-
ure 4B, we performed BLASTN alignments for the cross-
hybridizing virus probe sequences with the sequence of
JEV, and found that none of the probe sequences had sig-
nificant sequence similarity with JEV. Thus, the sequence
complementarity guidelines do not explain why the JEV
viral sample cross-hybridized to the other three non-target
probes – this might instead be attributable to non-
Watson-Crick base pairing [17-20].
In addition to the cross-hybridization issue, different
probes for the same virus can yield very different signal
intensities (e.g., the signal intensity for one probe was
more than 100-fold lower than that for the other probe for
the SARS-CoV virus, see Additional File 2). This may be
attributed to the combination of the sequence-dependent
effects of DNA hybridization [21,22] and the failure of
random-primed PCR amplification to amplify the target
regions of the probes.
Collectively, nucleic acid hybridization involves complex
mechanisms that cannot yet be predicted purely by com-
putation. Cross-hybridization and sequence-dependent
variation in hybridization efficiency may be unavoidable
in hybridization reactions involving a large number of
probes, such as in the microarray method, making it desir-
able to have multiple specific probes for each virus.
Viruses can be identified on the basis of the specific signal
strength derived from the average signal intensity of mul-
tiple probes, since the cross-hybridization signals are
always lower for the nontarget sequences than for the tar-
get sequences (which are a perfect match) [10,14-16,21].
There are, however, limitations to the virus microarray
approach described here. An obvious one is that the range
of viruses detectable by the method is limited by the con-
tent of viral genera archived in the database. Therefore, if
the emerging new virus belongs to a heretofore unknown
genus, then none of the probes would reveal a detectable
hybridization signal.BMC Bioinformatics 2006, 7:232 http://www.biomedcentral.com/1471-2105/7/232
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Although our method ensures identification accuracy by
verifying the results with the concordant taxonomical
association of a genus and species, it is common for an
assay sample to contain viruses of more than one genus or
more than one species of viruses belonging to the same
genus. As described in the Methods section, the viral
genus is assigned using a scoring method based on signal
strength; that is, Sum(Fe|G)/ (Sum(Fe|G)). If more than
one genus are present, there will be more than one non-
zero Sum(Fe|G) values. One of the genera will be given
100% and the others will be given a percentage smaller
than 100%. Whether the signals are true genus signals or
cross-hybridization signals can be verified by the presence
of hybridization signals from the cognate species-specific
probes. Only concordant genus and species identification
results are accepted for assigning virus identities, which is
one of the advantages of having separate probe sets for
genus and species identification.
Moreover, the situation is more difficult than the above
multigenus determination if more than one species
belonging to the same genus are present,. Accurate dis-
crimination of true signals from cross-hybridization
depends on setting the correct signal thresholds together
with discretion based on epidemiology statistics. High
threshold values for the signal strengths increase the virus
identification accuracy. As shown in Figure 4B, the cross-
hybridization signals are several-fold lower than the true
signal of JEV. Comparison with the results shown in Fig-
ure 4B reveals that the MEV, WNV, and LIV signals are
false not only based on the threshold setting but also from
the epidemiology statistics that coinfection or coexistence
of any of these viruses in one assay sample is highly
unlikely.
In this study we gathered virus information from Gen-
Bank which contains viral sequences of varying lengths,
qualities and redundancy. It is noted that the viral
sequences in GenBank are not well moderated [23] and
taxonomic discrepancies exist among the curated viral
databases available to the public, e.g., NCBI Viral Refer-
ence Genome collection [24] and the Universal Virus
Database of International Committee on Taxonomy of
Viruses (ICTVdB) [25]. This report describes an algorithm
for identifying conserved genus sequences from a viral
sequence database. The algorithm can be applied to any
publicly available viral sequence database. However, for
the purpose of computing conserved viral genus
sequences, a large number of available sequences are
needed and GenBank provides the most comprehensive
collection of viral sequences available to the public. The
large volume of data in GenBank fully satisfies the pur-
pose of the present study: to develop a universal and com-
prehensive chip for identifying viruses, regardless of
whether their genomes have been completely sequenced.
The proposed approach of employing genus- and species-
specific probe sets makes it possible to minimize the
number of probes and cover all known viruses, including
animal- and plant-infecting viruses, on a single chip.
Conclusion
Most existing virus detection and identification methods
are capable of identifying only a small number of known
viruses in a single assay. Parallel screening for a broad
spectrum of uncharacterized viruses using microarray
technology overcomes this limitation and also provides a
means of discovering emerging new viruses. Our probe
design concept employs a panel of conserved sequence
probes to directly classify emerging or unsequenced
viruses at the genus level, and specific probes for known
virus identification in a direct-readout manner. Moreover,
using the two types of probes to determine the identity of
a virus in a complementary way further assures detection
accuracy. The ability to detect a large variety of viruses
using the virus microarray approach has great potential in
facilitating the discovery of emerging viruses and diagnos-
ing diseases of unknown etiology or patients infected with
unknown or multiple simultaneous viral pathogens.
In summary, we have established a virus probe design
method and virus identification process for viral classifi-
cation and identification based on a microarray approach.
Our new probe design strategy and virus detection
method allow direct reading of virus identity, and differ
significantly from the probe design and virus detection
methods described in the literature [2,26]. The concept
and feasibility have been demonstrated using several
example viruses. The methods and protocols can be
applied to the analysis of large-scale virus microarray data
to determine the identities of detected viruses by direct
readout of a computer program.
Finally, the genera and species-specific probes for more
than 5,700 viruses are archived in a database that is avail-
able on the Internet http://genestamp.sinica.edu.tw/
virus/index.htm. To our knowledge, this database is the
most comprehensive virus probe database currently avail-
able to the public. The use of the new probe design algo-
rithm, which does not involve tiling probes, reduces the
number of probes on a virus microarray yet retains high
identification accuracy. The new probe design method
makes it feasible to construct a virus microarray with suf-
ficient probes for identifying all the sequenced viruses that
infect animals and plants.
max
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Methods
Virus identity determination
We developed the following identification procedure to
compute the identity of a virus directly from the hybridi-
zation signals. First, to minimize nonspecific hybridiza-
tion, any probe with a fluorescence signal intensity, F,
satisfying the following two criteria is eligible to use in the
subsequent viral identification procedure: (i) Fviral sample/
Fblank ≥ 3 and (ii) Fviral sample – Fblank > 1500. To take both the
number and signal intensity of probes satisfying the above
criteria in a given genus probe set into consideration, the
following genus signal strength (defined as a percentage)
is used to determine the viral genus identity: Sum(Fe|G)/
(Sum(Fe|G)), where Fe|G represents the hybridization
intensity of any eligible genus probe in a genus G,
Sum(Fe|G) is the sum of all the Fe|G  in  G, and
(Sum(Fe|G)) represents the maximum value of
Sum(Fe|G) among all the viral genera represented on a
microarray. The viral genus identity in a test sample is
assigned to the genus with the highest genus signal
strength (i.e., 100%). The presence of multiple viruses of
different genera in a sample will result in a nonzero genus
signal strength. We then score and rank the possible virus
identities in the specific probe region on the basis of the
specific signal strength, defined as the average signal inten-
sity of the multiple probes for a given virus divided by the
maximum average signal intensity of the multiple probes
for every virus represented on a microarray (expressed as
a percentage). As for the genus determination method, the
presence of multiple viruses in the sample will result in a
nonzero signal strength. Finally, the identity of the virus is
established by the concordant results for both the genus-
and cognate-species-specific probes.
Array fabrication
Oligonucleotides of 70 mers were synthesized and modi-
fied with 5' amino-linker moieties by standard phosphor-
amidite-synthesis chemistry on a homemade DNA
synthesizer [27], and desalted by Sephadex (G50 DNA
grade; Amersham, NJ). The 70-mer oligonucleotide
probes were dissolved in Pronto! Epoxide spotting solu-
tion (Corning, NY) at a concentration of 40 μM and spot-
ted on Corning Epoxide glass slides using a homemade
arrayer. The slides were processed according to the manu-
facturer's instructions.
Cell culture and viruses
The JEV (RP-9 strain, GenBank accession number:
AF014161) and DEN-2 (PL046 strain), DEN-3 (H87
strain), and DEN-4 (H241 strain) used in this study were
propagated in C6/36 cells using RPMI 1640 medium con-
taining 5% fetal bovine serum (FBS) (Invitrogen, CA). The
EV71 (neu strain) stock was propagated in RD cells cul-
tured in DMEM (Dulbecco's modified Eagle's medium)
supplemented with 2% FBS, penicillin (100IU/ml), and
streptomycin (100 IU/ml). SARS-CoV RNA was kindly
provided by the Taiwan Center for Disease Control. The
copy number of SARS-CoV genomes in a sample was
measured using a commercially available quantitative RT-
PCR kit (RealArt™ HPA-Coronavirus LC RT PCR Reagents,
ARTUS, Germany). The amount of viruses used in the
study were as follows: (i) 1.75 × 104 pfu of DEN-2, (ii) 3.5
× 103 pfu of DEN-3, (iii) 1.75 × 103 pfu of DEN-4, (iv) 13
μg of total RNA derived from JEV-infected A549 lung ade-
nocarcinoma cells, (v) 1.5 × 104 copy numbers of SARS-
CoV, (vi) 2.33 × 103 pfu of EV7, and (vii) a mixture of 2.33
× 103 pfu of EV71 and 100 copy numbers of the SARS-CoV
viral genome. The blank control was 11.2 μg of total RNA
derived from A549 lung adenocarcinoma cells.
Sample amplification, labeling, hybridization, and data 
analysis
The viral genomic sequences were randomly amplified as
described previously [2,28]. The amplified PCR product
was purified with the MiniElute PCR purification kit (Qia-
gen, CA). Cy3-dUTP was incorporated into the purified
PCR product with random octamers using the Klenow
fragment of DNA polymerase I. The hybridization of the
Cy3-labeled DNA fragments to the Corning Epoxide slide
was performed at 42°C for 16–18 hr in Pronto! microar-
ray hybridization buffer (Corning) under an 18 × 18 mm
coverslip in a sealed chamber. After hybridization, the
arrays were washed three times with Pronto! washing rea-
gents. After drying by centrifugation, the arrays were
scanned with a GenePix 4000B scanner (Axon Instru-
ments, CA). Array image acquisition and signal analysis
were performed using GenePix Pro 4.0 software.
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Additional File 1
Example description of step 5 of the probe design algorithm. This file 
contains a description of step 5 of the probe design algorithm. Example 
viruses are used to illustrate how this step identifies conserved sequences 
for a viral genus.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-7-232-S1.doc]
Additional File 2
Virus probe sequences on the test chip, and hybridization data of the 
probes to various samples. This file contains information on the probes 
and experimental hybridization data of the test chips used in an empirical 
approach to demonstrate the validity of the probe design algorithm.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-7-232-S2.xls]